The University of Chicago Header Logo

Connection

Joseph Caprini to Fibrinolytic Agents

This is a "connection" page, showing publications Joseph Caprini has written about Fibrinolytic Agents.
Connection Strength

1.727
  1. Balancing the risk of complications in foot and ankle surgical patients taking antithrombotic medication. Foot Ankle Spec. 2014 Dec; 7(6):507-14.
    View in: PubMed
    Score: 0.370
  2. Intermittent pneumatic compression and pharmacologic thrombosis prophylaxis. Curr Opin Pulm Med. 2009 Sep; 15(5):439-42.
    View in: PubMed
    Score: 0.263
  3. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations. Ann Surg. 2009 Aug; 250(2):219-28.
    View in: PubMed
    Score: 0.262
  4. Compliance with antithrombotic guidelines. Manag Care. 2006 Sep; 15(9):49-50, 53-60, 66.
    View in: PubMed
    Score: 0.214
  5. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
    View in: PubMed
    Score: 0.138
  6. Can combined (mechanical and pharmacological) modalities prevent fatal VTE? Int Angiol. 2011 Apr; 30(2):115-22.
    View in: PubMed
    Score: 0.073
  7. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010 Sep; 126(3):175-82.
    View in: PubMed
    Score: 0.069
  8. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thrombo-embolism in high-risk patients. Eur J Vasc Endovasc Surg. 2009 Mar; 37(3):364-5.
    View in: PubMed
    Score: 0.063
  9. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry. Thromb Haemost. 2008 Mar; 99(3):546-51.
    View in: PubMed
    Score: 0.059
  10. Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use. Int Angiol. 2008 Feb; 27(1):60-7.
    View in: PubMed
    Score: 0.059
  11. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med. 2005 Jul 11; 165(13):1458-64.
    View in: PubMed
    Score: 0.049
  12. Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary results. J Vasc Surg. 1996 Apr; 23(4):616-21.
    View in: PubMed
    Score: 0.026
  13. Development of a Novel Composite Process Measure for Venous Thromboembolism Prophylaxis. Med Care. 2016 Feb; 54(2):210-7.
    View in: PubMed
    Score: 0.026
  14. Thromboelastography: measuring statistical probabilities. Semin Thromb Hemost. 1995; 21 Suppl 4:14-20.
    View in: PubMed
    Score: 0.024
  15. Thromboembolic diseases. Curr Probl Surg. 2008 Dec; 45(12):844-99.
    View in: PubMed
    Score: 0.016
  16. The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients. J Vasc Surg. 2003 Nov; 38(5):916-22.
    View in: PubMed
    Score: 0.011
  17. Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution. Thromb Res. 1974 Feb; 4(2):199-217.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.